Brian Buttrick
About Brian Buttrick
Brian Buttrick serves as the Director of Platform at Johnson & Johnson Innovative Medicine, a position he has held since 2024. He has a background in software engineering and research, with previous roles at DuckDuckGo and the University of Washington.
Current Role at Johnson & Johnson Innovative Medicine
Brian Buttrick has been serving as the Director of Platform at Johnson & Johnson Innovative Medicine since 2024. In this role, he focuses on the strategic development and implementation of platform technologies that support innovative medical solutions. His tenure at Johnson & Johnson marks a significant step in his career, where he applies his extensive experience in software engineering and research to advance the company's initiatives.
Experience at Serotiny
Brian Buttrick has held the position of Director of Platform at Serotiny since 2020. His responsibilities include overseeing platform development and ensuring the integration of cutting-edge technologies in the company's projects. His role at Serotiny reflects his commitment to advancing biotechnological solutions and enhancing the company's capabilities in the field.
Previous Experience at DuckDuckGo
Before joining Serotiny, Brian Buttrick worked as a Lead Software Engineer at DuckDuckGo from 2014 to 2020. In this position, he contributed to the development of the search engine's features and performance. His work at DuckDuckGo involved collaborating with cross-functional teams to enhance user experience and ensure data privacy.
Research Background at University of Washington
Brian Buttrick's research career includes two separate tenures as a Research Scientist at the University of Washington. He worked from 2010 to 2012 and again from 2012 to 2014. During his time at the university, he engaged in various research projects that contributed to advancements in the fields of biochemistry and pharmaceutics.
Education and Academic Qualifications
Brian Buttrick studied at the University of Washington, where he earned a Bachelor of Science (BS) in Biochemistry and a Master of Science (MS) in Pharmaceutics. His academic background provides a strong foundation for his work in both research and software engineering, enabling him to bridge the gap between technology and life sciences.